https://www.pharmaceutical-technology.com/news/symcel-test-calscreener-antibiotic-susceptibility/ 2018-04-12T11:26:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rigel-kidney-disease-drug-trial/ 2018-04-12T13:00:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/study-shows-antiepileptics-enhance-dementia-risk/ 2018-04-11T09:49:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-licences-ionis-nash-drug-candidate/ 2018-04-11T12:36:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-provide-75m-advance-prostate-cancer-treatment/ 2018-04-11T11:29:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/quralis-seed-funding-als-research/ 2018-04-12T13:02:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/results-merck-incyte-cancer-trials-epacadostat/ 2021-10-29T05:21:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-government-dmd-drug-price/ 2023-01-23T13:19:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-rejects-roche-ms-drug-ocrelizumab/ 2018-04-12T13:07:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-researchers-find-40-genes-associated-myeloma/ 2018-04-10T10:15:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-closes-1-9bn-flatiron-health-acquisition/ 2018-04-10T09:59:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/antibiotics-may-treat-drug-resistant-bacterial-infections/ 2018-04-10T10:37:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/long-will-infliximab-biosimilars-dominate-us-anti-tnf-market/ 2018-04-09T12:21:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/johnson-37m-baby-powder-cancer/ 2018-04-09T09:02:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-dndi-develop-visceral-leishmaniasis-therapy/ 2023-06-14T07:02:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-agrees-take-avexis-8-7bn/ 2018-04-09T10:38:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-gets-rights-epidestinys-blood-disease-drug/ 2018-04-09T10:00:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/tetra-granted-fda-orphan-drug-designation-fxs-treatment-will-enough/ 2018-04-06T15:01:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/sunovions-nda-submission-adds-fuel-rivalry-acorda/ 2018-04-06T14:49:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/drug-approval-forecast-highlights-increasing-profits-biktarvy-erleada/ 2018-04-06T11:11:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-lansen-pharmaceutical-fagron-hunan/ 2018-04-05T11:22:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/age-related-macular-degeneration-sales-reach-11-5bn-2026/ 2018-04-06T10:47:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-artificial-enzyme-employs-light-bacteria/ 2018-04-09T09:05:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-twist-bioscience-kangmei-pharmaceutical-daiichi-sankyo/ 2018-04-06T08:42:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-ose-immunotherapeutics-develop-new-cancer-drug/ 2018-04-09T09:06:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-sigilon-collaborate-diabetes/ 2018-04-05T16:26:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/us-drug-pricing-industry-regulate/ 2018-04-05T15:37:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/award-winning-pharma-packaging/ 2018-04-05T15:13:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/microbiome-targeted-immunotherapies-getting-pricing-right/ 2018-04-05T14:36:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/sanofi-got-dance/ 2018-04-05T13:43:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/allergan-phase-iii-results-bipolar-drug/ 2018-04-05T08:22:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/glenmark-signs-deal-helsinns-akynzeo-india-nepal/ 2018-04-05T10:28:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/stanford-university-devises-new-way-make-noscapine-drug/ 2023-05-31T05:24:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/anti-egfr-tnf-combination-may-treat-lung-cancers/ 2018-04-05T10:50:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pg-pfizer-consumer-healthcare-gsk/ 2018-04-05T08:32:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-consumer-healthcare-novartis/ 2018-04-05T08:33:53+00:00 daily 1.0 https://www.pharmaceutical-technology.com/comment/contract-manufacturers-must-fill-capability-gaps-benefit-cell-therapy-approvals/ 2018-04-04T14:59:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/medimmune-signs-license-deal-compugen-antibody-products/ 2018-04-04T10:21:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/allogene-enters-asset-contribution-agreement-pfizers-car-t-drugs/ 2018-04-04T10:08:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-review-sanofis-dupixent-drug-asthma/ 2018-04-04T09:55:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/leukaemia-astrazeneca-license/ 2018-04-09T10:48:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alkermes-refusal-file-depression-drug/ 2018-04-05T08:32:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pfizers-pipeline-specialisation/ 2018-04-03T15:12:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/counter-availability-will-boost-viagra-sales/ 2018-04-03T14:58:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-trial-cardiac-disease-drug/ 2018-04-03T14:48:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-issue-69/ 2023-04-12T06:08:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/geographic-scope-biosimilar-regulatory-pathways-little-late/ 2018-04-03T12:47:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/shooting-future-hold-growth-drugs/ 2018-03-26T15:06:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgens-blincyto-gets-us-approval-acute-lymphoblastic-leukaemia/ 2018-04-03T10:45:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/2018-march-top-stories-pharma/ 2018-04-05T09:29:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-rna-based-therapy-can-potentially-treat-west-nile-virus/ 2018-04-03T12:57:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lung-cancer-drug-crizotinib-may-targeted-breast-cancer-therapy/ 2018-04-03T12:59:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-manufacturing-hotspots/ 2021-11-22T09:34:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-jaguar-health-sichuan-kelun-pharmaceutical-ptc-therapeutics/ 2018-03-29T08:44:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-glaxosmithkline-bal-pharma-novaquest-capital-management/ 2018-03-29T08:55:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-committee-approve-lofexidine-opioid/ 2018-03-29T16:30:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fujifilm-acquires-companies-800m/ 2018-03-29T16:23:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-shire-takeover/ 2018-03-29T16:15:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/regeneron-potential-succeed-despite-lacklustre-share-performance/ 2018-03-29T09:45:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accepts-bms-sbla-opdivo-yervoy-colorectal-cancer/ 2018-03-29T08:58:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/racemisation-risk-new-tool-identify-drugs-destined-fail/ 2018-03-26T14:45:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-grants-breakthrough-therapy-designation-fennecs-pedmark/ 2018-03-29T13:58:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daiichi-sankyo-partners-research-new-cancer-therapy/ 2018-03-29T11:08:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/protagonistsphase-iib-ulcerative-colitis/ 2018-03-28T16:22:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mercks-tepotinib-fast-track-japan/ 2018-03-28T15:54:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-flu-vaccine/ 2018-03-28T15:43:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/roches-tecentriq-avastin-may-upper-hand-renal-cancer/ 2018-03-28T13:21:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pricing-adjustments-car-t-therapies-likely-2018-beyond/ 2018-03-28T12:58:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/step-towards-earlier-detection-parkinsons-disease/ 2023-01-30T15:54:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-androgel-lawsuit-testosterone/ 2018-03-28T09:31:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/seamless-trials-key-drug-approvals/ 2022-07-11T08:55:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tracelink-finds-disparity-pharma-industry-serialisation-targets/ 2018-03-28T11:35:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/virtual-tumour-model-improve-targeted-cancer-treatment/ 2018-03-28T10:10:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uvas-new-trial-aims-help-lung-transplant-recipients/ 2018-03-28T10:42:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/global-osteoporosis-market-reach-11-2bn-2027/ 2023-05-15T03:54:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/gsk-enlists-retail-pharmacies-hasten-us-uptake-shingrix/ 2018-03-27T15:28:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/first-big-pharma-company-distribute-medical-cannabis-products/ 2018-03-27T14:14:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/rituximab-biosimilars-hype-warranted/ 2018-03-27T10:24:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-ablynx-lupus-phase-ii-trial/ 2022-07-11T08:55:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/legitimising-stem-cell-therapies-path-fda-approval/ 2018-03-27T09:57:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/turning-heat-nano-research/ 2018-03-26T14:30:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-acquire-novartis-stake-healthcare-jv-13bn/ 2018-03-27T09:59:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/canadian-study-finds-daily-ibuprofen-can-prevent-alzheimers/ 2018-03-27T11:53:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-viivs-juluca-gets-chmp-recommendation-hiv-1/ 2018-03-27T10:41:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/the-economic-impact-of-diagnosed-diabetes-html/ 2021-11-02T03:27:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eu-allogenic-crohns-alofisel/ 2018-03-26T15:01:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/fdas-biosimilars-push-will-interchangeability-requirements-change/ 2018-03-26T10:44:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/riding-nektars-wave-cytokine-immunotherapies-oncology/ 2018-03-26T09:45:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-pulls-out-of-20bn-auction-of-pfizer-consumer-healthcare/ 2018-04-04T11:21:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-phase-iii-ms-siponimod/ 2018-03-26T09:05:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/augusta-university-develops-new-chimera-molecule-breast-cancer/ 2018-03-26T10:27:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-merck-get-japanese-regulatory-approval-lenvima/ 2018-03-26T12:10:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/european-chmp-recommends-sandozs-biosimilar-infliximab/ 2018-03-26T10:45:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/barricading-front-door-colombias-moves-toward-valuebased-pricing-html/ 2021-11-02T03:27:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-tasigna-gets-approval-for-rare-leukaemia-in-us-children/ 2018-03-23T12:05:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/japans-shionogi-signs-carb-x-partnership-to-tackle-cre-superbug/ 2018-03-23T12:10:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/study-finds-about-60-of-drug-safety-experts-prefer-ai/ 2018-03-26T11:27:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-vistin-pharma-shenzhen-neptunus-bioengineering/ 2018-03-23T08:54:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-otsuka-pharmaceutical-factory-shin-kowa-pharmaceutical/ 2018-03-23T09:15:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/akceas-fcs-drug/ 2023-01-04T11:15:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mps-cystic-fibrosis-orkambi-nhs/ 2018-03-22T17:07:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/block-lock-functional-cure-hiv/ 2018-03-22T11:40:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/croi-2018-early-stage-rd-sets-guideposts-future-cmv-therapies/ 2021-11-22T14:32:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tcr2-125m-funding-t-cell/ 2018-03-22T10:04:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regeneron-alnylam-find-new-rnai-drugs-nash-disease/ 2018-03-22T11:43:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/helsinn-purchase-skin-cancer-drug-valchlor-actelion/ 2018-03-22T10:36:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-forms-new-partnership-better-study-multiple-myeloma/ 2018-03-22T12:08:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-rejects-dompes-drug-cenegermin/ 2018-03-21T17:08:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pfizers-rituximab-biosimilar-edges-closer-approval/ 2018-03-21T11:34:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/thermo-fisher-job-cuts-brexit/ 2018-03-21T09:36:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-joins-efforts-to-develop-new-medical-treatments/ 2018-03-21T11:49:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-expands-lymphoma-indications-for-seattle-genetics-adcetris/ 2018-03-21T16:14:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/prothena-partners-with-celgene-for-new-neurodegenerative-therapies/ 2018-03-21T16:18:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-obesity-semaglutide-trial/ 2022-07-11T08:56:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nhs-pharmacists-care-homes/ 2018-03-21T11:03:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pistoia-alliance-calls-life-sciences-firms-support-lab-future/ 2018-03-20T12:25:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tilray-partners-sandoz-canada-develop-medical-cannabis-products/ 2018-03-20T12:44:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizers-snda-xtandi-gets-priority-review-prostate-cancer/ 2018-03-20T12:34:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abivax-2017-report-hiv-research/ 2018-03-19T16:23:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/hope-horizon-obesity-market/ 2018-03-20T14:36:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/thermo-fisher-invest-new-pharma-services-facility-germany/ 2018-03-19T12:39:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/merck-positions-keytruda-success-bladder-cancer-space/ 2018-03-19T11:38:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/digital-health-new-direction-neurology/ 2023-03-03T11:22:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cytoreason-ai-anti-inflammatories/ 2018-03-19T09:30:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bavarian-nordic-develop-vaccine-equine-encephalitis/ 2018-03-19T11:35:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lundbeck-buy-netherlands-prexton-therapeutics-e905m/ 2018-03-19T16:46:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/auris-tinnitus-treatment-fails-trial/ 2022-07-11T08:56:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cfda-reform/ 2018-03-21T11:02:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-supernus-pharmaceuticals-vanda-pharmaceuticals-intellipharmaceutics-international/ 2018-03-16T09:55:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nih-funded-trials-h7n9-influenza-vaccine-begin-enrolment-us/ 2018-03-16T11:12:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ionis-akcea-enter-licensing-deal-two-rare-disease-drugs/ 2018-03-16T12:56:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-seattle-genetics-gryphon-investors-chryscapital/ 2018-03-16T10:01:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssens-urothelial-cancer-drug-gets-breakthrough-therapy-designation/ 2018-03-16T12:46:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/2018-year-making-strategic-alliances-dmd/ 2018-03-15T11:23:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/advaxis-trial-death/ 2023-01-04T11:33:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ono-pharma-merus-sign-licence-deal-bispecific-antibody/ 2018-03-15T16:39:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/canadian-us-scientists-partner-fight-brain-diseases/ 2018-03-15T11:46:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/certara-forms-consortium-immuno-oncology-simulation/ 2018-03-15T12:25:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/right-to-try-bill-house-approval/ 2018-03-16T11:19:22+00:00 daily 1.0 https://www.pharmaceutical-technology.com/comment/blockbuster-oncology-deal-merck-eisai/ 2018-03-14T13:34:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abcellera-develop-response-platform-viral-pandemics/ 2018-03-14T11:51:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringers-new-project-vanderbilt-targets-cancer/ 2018-03-14T12:31:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/anti-cancer-drug-may-reverse-social-deficits-associated-autism/ 2022-12-20T10:15:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/risksharing-as-a-path-forward-for-mexico-html/ 2021-11-02T03:27:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/addiction-gene-kifc1-breast-cancer/ 2018-03-13T16:53:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ritter-data-lactose-intolerance-trial/ 2022-07-11T08:56:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vbl-halts-phase-iii-rgbm-trial/ 2018-03-13T12:52:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/universal-flu-vaccine-horizon/ 2018-03-13T11:30:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/taimeds-trogarza-large-impact-hiv-treatment/ 2018-03-23T15:04:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tae-technologies-forms-life-sciences-subsidiary/ 2023-08-08T04:57:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sarepta-therapeutics-seek-fda-approval-golodirsen/ 2018-03-13T10:50:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/glp-1-agonists-sglt-2-inhibitors-sales-surpassed-8bn-2017/ 2018-03-13T11:49:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-pfizer-schizophrenia-590m/ 2018-03-12T17:32:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ai-atomwise-45m-drug-research-technology/ 2018-03-12T12:20:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/seattle-genetics-concludes-cascadian-therapeutics-acquisition/ 2018-03-12T11:40:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/labcorps-covance-forms-new-biologic-drug-development-unit/ 2018-03-12T11:11:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/researchers-in-belgium-identify-new-antifungal-compounds/ 2022-03-25T07:49:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cigna-express-scripts-67-billion/ 2018-03-12T12:08:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/non-opioid-better-opioids-chronic-pain/ 2018-03-09T14:23:58+00:00 daily 1.0 https://www.pharmaceutical-technology.com/comment/potential-drug-repurposing-orphan-drug-development/ 2018-03-09T13:26:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/can-big-data-improve-diagnosis-rare-diseases/ 2018-03-09T11:00:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-talks-evotec-anti-infectives-rd-platform/ 2018-03-09T16:18:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/prevail-therapeutics-gets-funding-support-gene-therapies/ 2018-03-09T10:10:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-mas-week-zydus-cadila-healthcare-eisai-tabuk-pharmaceuticals-manufacturing-company/ 2018-03-09T10:06:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-study-finds-il-7-can-boost-immunity-sepsis/ 2018-03-09T15:59:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-fda-approval-dengvaxia/ 2018-03-08T17:21:27+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/pfizer-swansea-university-innovation-hub/ 2018-03-08T14:15:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/researchers-combine-immunotherapy-hydrogel-treat-cancer/ 2018-03-08T11:36:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cepi-awards-funding-themis-lassa-fever-mers-vaccines/ 2022-12-02T14:42:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-merck-partner-develop-sell-cancer-drug-lenvima/ 2018-03-08T12:23:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/starving-bacteria-iron-amr/ 2018-03-07T17:12:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cantrell-restraining-order-fda/ 2018-03-07T16:09:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pharma-firms-investing-cyber-security/ 2018-06-21T14:31:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ms-drug-zinbryta-withdrawn-deadly-safety-issues-reported/ 2018-03-07T10:13:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celgene-completes-9bn-juno-therapeutics-acquisition/ 2018-03-07T17:45:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-taimeds-trogarzo-treat-hiv/ 2018-03-07T11:06:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nih-trial-finds-short-term-tuberculosis-therapy-effective/ 2018-03-07T17:31:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-study-hiv-art/ 2018-03-07T10:16:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cracking-mysteries-alzheimers-disease/ 2018-03-06T15:27:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/homology-100-million-ipo/ 2018-03-09T16:49:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accepts-sanofis-sbla-dupixent-asthma/ 2023-05-30T04:27:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vividion-celgene-sign-drug-discovery-deal/ 2018-03-06T10:49:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/crispr-identifies-possible-drug-targets-als/ 2018-03-06T17:29:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/february-2018-top-news-stories-pharma/ 2018-03-06T17:26:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/theresa-may-ema-brexit/ 2018-03-06T09:31:36+00:00 daily 1.0 https://www.pharmaceutical-technology.com/comment/2017-tipping-point-oncology-biosimilar-space/ 2018-03-05T11:08:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rubius-rcts/ 2018-03-05T09:30:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-researchers-invent-immunotherapy-y-traps-fight-cancer/ 2018-03-05T11:51:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-abbvie-voluntarily-withdraw-zinbryta-authorisations/ 2018-03-05T12:13:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-agreement-accelerate-drug-rd-uk/ 2018-03-05T12:39:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-sorrento-painkiller-patch/ 2018-03-05T10:35:35+00:00 daily 1.0 https://www.pharmaceutical-technology.com/comment/biopharma-financing-showed-healthy-growth-january/ 2018-03-02T11:19:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-pear-digital-therapeutics-apps/ 2018-03-02T10:17:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-sms-lifesciences-india-merck-teijin/ 2018-03-02T16:18:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-pfizer-n4-pharma-tesaro/ 2018-03-01T13:20:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-partners-pear-therapeutics-develop-digital-therapies/ 2018-03-07T14:30:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/second-genome-forms-four-new-alliances-immuno-oncology-rd/ 2018-03-02T16:35:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/report-ckd-induced-comorbidity-drug-market-witness-9-5-cagr/ 2018-03-02T12:45:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cost-effectivity-mengitis-vaccines/ 2023-03-31T10:42:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/eus-falsified-medicines-directive-set-bring-scheduling-burdens-manufacturers/ 2018-03-01T13:54:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/increasing-dose-outsourcing-masks-long-term-concerns/ 2018-03-01T13:43:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/moderate-growth-multiple-sclerosis-market/ 2018-03-01T11:16:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/poor-seasonal-influenza-efficacy-necessitates-shift-away-egg-based-manufacturing/ 2018-03-01T10:59:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celgene-ms-drug-rejected-fda/ 2018-03-01T10:09:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/beigenes-revlimid-receives-chinese-approval-multiple-myeloma/ 2018-03-01T12:09:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mylan-revance-develop-market-botox-biosimilar/ 2018-03-01T12:13:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/study-finds-20-prescribed-antibiotics-england-inappropriate/ 2018-03-01T13:30:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/gsk-dynavax-clear-winners-2017-vaccines-space/ 2018-02-28T19:58:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astra-zeneca-autoimmune-spinout/ 2018-03-01T09:40:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/proposed-fda-budget-increase-boost-continuous-manufacturing-approvals/ 2018-02-28T11:49:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/biosimilars-celltrion-paves-way-herceptin-copycats-2018/ 2018-02-28T11:24:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/protein-cancer-drug-resistance/ 2018-03-01T09:42:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-lillys-verzenio-advanced-breast-cancer/ 2018-02-28T10:37:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/precision-therapeutics-forms-new-tumorgenesis-subsidiary/ 2018-02-28T12:10:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-forms-drug-research-alliance-aldeyra-therapeutics/ 2018-02-28T10:55:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/on-the-road-to-hta-harmonization-in-europe-html/ 2021-11-02T03:27:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/pfizer-owe-nhs-5m/ 2018-02-27T17:28:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-kempharm-opioid-apadaz/ 2018-02-27T16:01:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/fentanyl-go-wrong/ 2024-07-23T11:25:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/kite-sangamo-partnership-bucks-trend-crispr-based-cancer-therapeutics/ 2018-02-27T10:46:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/mercks-viralytics-deal-reinforces-keytruda-centric-oncology-franchise/ 2018-02-27T10:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/most-read/pharma-technology-focus-issue-68/ 2023-04-12T06:47:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nih-joins-efforts-address-two-common-bacterial-infections/ 2023-01-19T06:23:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/elsevier-beijing-university-expand-chinese-medicine-database/ 2018-02-27T10:47:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/acg-joins-applied-dna-prevent-capsule-counterfeiting/ 2018-02-27T11:49:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pcsk9-inhibitors-grew-steadily-dyslipidemia-market-last-year/ 2023-07-07T04:13:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/uks-largest-pharma-companies-oppose-leaving-customs-union/ 2018-02-26T11:13:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lynparza-tablets-get-positive-chmp-opinion-ovarian-cancer/ 2018-02-26T11:09:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-announces-45m-funding-brain-tumour-research/ 2018-02-26T11:16:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/swiss-researchers-study-new-il-18-inhibitor-stills-disease/ 2018-02-26T11:54:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mini-tumour-test-cancer/ 2018-02-23T16:43:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-breast-cancer-drug-nice/ 2018-02-26T09:45:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trial-tracker-data-unpublished/ 2018-03-05T10:45:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-creso-pharma-mundipharma-roche/ 2018-02-22T14:46:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-n4-pharma-segulah-venture-allergan/ 2018-02-23T10:04:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/benevolentai-buys-research-facility-support-drug-development/ 2018-02-23T10:27:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kite-sangamo-develop-new-cell-therapies-cancer/ 2018-02-23T12:26:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/report-forecast-sees-rise-need-supportive-cancer-care/ 2018-02-23T12:50:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/atrazeneca-antisense-deal-ionis/ 2018-02-22T17:20:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/gilead-led-global-infectious-diseases-space-2017/ 2018-11-19T14:53:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/aad-2018-strong-phase-iib-results-upadacitinib-atopic-dermatitis/ 2018-02-22T11:05:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/will-amazon-new-face-healthcare/ 2018-02-22T10:55:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-acquire-australias-viralytics-394m/ 2018-02-22T09:56:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oric-pharma-advance-oric-101-treatment-resistant-cancers/ 2018-02-22T10:13:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-wave-life-sciences-develop-neurological-treatments/ 2018-02-22T10:26:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/organ-chip-partnership-roche-takeda/ 2018-02-21T17:11:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/blood-test-detect-autism/ 2018-02-28T17:07:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ophthalmology-biosimilars-market-still-infancy/ 2018-02-21T11:49:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/aad-2018-tremfya-cost-effective-cosentyx-taltz/ 2018-02-21T11:47:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/biogen-continues-dominate-neurology-market/ 2018-02-21T11:18:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/aad-2018-abbvies-risankizumab-boasts-strong-phase-iii-data-psoriasis/ 2018-02-21T09:46:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-voyager-target-one-time-treatment-alzheimers/ 2018-02-21T11:30:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zealand-pharma-uniquest-develop-new-peptide-therapeutics/ 2021-11-22T08:55:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-study-finds-genetic-cause-behind-drug-resistant-typhoid-strain/ 2018-02-21T12:32:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/small-pharma-steals-spotlight-2017-antibiotics-space/ 2018-02-20T16:14:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gileads-patent-merck-overturned/ 2018-02-20T12:04:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-researchers-make-new-discoveries-brain-health/ 2018-02-20T09:42:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/arix-bioscience-fosun-partner-develop-new-clinical-therapies/ 2018-02-20T12:20:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hansa-medicals-ides-obtains-fda-orphan-drug-status/ 2018-02-20T09:55:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/defines-counter-drug/ 2020-01-31T13:48:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-astrazeneca-imfinzi/ 2018-02-20T14:35:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nhs-cutbacks-clinical-trials/ 2018-02-20T14:52:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/biosimilars-past-future-deals/ 2018-02-19T11:39:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oxford-biomedica-bioverativ-enter-100m-gene-therapy-deal/ 2018-02-19T10:19:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-introduces-qvar-redihaler-inhalation-aerosol-us/ 2018-02-19T10:30:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/researchers-develop-new-stem-cell-based-stroke-treatment/ 2018-02-19T13:02:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/anticoagulants-drive-market-growth-multiple-cardiovascular-disease/ 2023-01-19T06:06:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/eylea-drives-sales-top-ophthalmology-players-2017/ 2018-02-16T15:02:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-approves-thyroid-lenvima/ 2018-02-16T11:24:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/lupin-launches-us-tamiflu-generic-amid-worst-flu-season-recent-memory/ 2018-02-16T10:43:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/top-players-cardiovascular-disease-2017/ 2018-02-16T10:13:48+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/novartis-forms-alliance-develop-diarrheal-disease-drug/ 2023-01-05T05:15:00+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/mas-week-astellas-pharma-shenzhen-neptunus-bioengineering-mallinckrodt/ 2018-02-16T09:45:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/report-melanoma-sales-reach-5-5bn-2026/ 2018-02-16T13:15:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-take-flatiron-health-1-9bn/ 2018-02-16T11:10:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-sichuan-languang-development-avadel-pharmaceuticals-cerecor/ 2018-02-16T12:27:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/machine-learning-technology-predicts-outcomes-chemical-reactions/ 2018-02-15T17:20:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-halts-alzheimers-trial/ 2022-12-02T14:45:23+00:00 daily 1.0 https://www.pharmaceutical-technology.com/comment/top-players-metabolic-disorders-2017/ 2018-02-15T14:22:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trumps-budget-fda-generics-market/ 2018-02-15T12:32:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/using-mrna-target-tumours/ 2018-02-15T11:00:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/two-pipeline-drugs-added-alzheimers-graveyard-2017/ 2018-02-15T10:45:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mallinckrodt-concludes-sucampo-pharma-acquisition-1-2bn/ 2018-02-15T10:31:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-researchers-discover-new-antibiotics-family-soil/ 2018-02-15T14:13:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/curevac-develop-mrna-vaccines-influenza-malaria/ 2018-02-15T10:38:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/bms-signs-3-6bn-deal-nektar-amid-changing-pd-1-pd-l1-landscape/ 2018-02-14T18:44:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/killer-cells-car-t-cancer-therapy/ 2018-02-23T09:25:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-production-method-see-widespread-use-biorenewables/ 2018-02-14T11:11:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-research-finds-living-artificial-tissue-repair-nerve-damage/ 2018-02-14T14:22:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-rejects-biomarins-rare-genetic-disorder-drug/ 2023-03-23T11:07:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/charles-river-laboratories-buy-mpi-research-800m/ 2018-02-14T11:23:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trial-spondylitis-drug-results/ 2022-07-11T08:56:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pharma-must-juggle-roi-social-concerns-tackle-tropical-diseases/ 2018-02-13T16:13:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/purdue-opioid-marketing/ 2018-02-20T14:44:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/will-us-tax-reform-initiate-next-wave-pharma-ma/ 2018-02-13T11:54:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/multidrug-resistant-cancer-treatment/ 2018-02-13T10:56:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/adc-bio-develops-new-method-produce-antibody-drug-conjugates/ 2018-02-13T11:04:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/seattle-genetics-pieris-pharma-enter-immuno-oncology-alliance/ 2018-02-13T12:47:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pci-pharma-services-intends-buy-australias-pharma-packaging-firm/ 2018-02-13T14:52:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-generics-guidances/ 2018-02-12T17:18:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cost-control-drug-pricing-policies-around-world/ 2024-07-23T11:25:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/gilead-viivs-hiv-rivalry-heats-biktarvy-approval/ 2018-02-12T15:09:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/despite-generic-erosion-major-product-gsk-maintains-strong-portfolio-respiratory-therapies/ 2018-11-19T14:52:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-focus-schizophrenia-therapies-development/ 2018-02-12T10:12:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-introduces-rebinyn-haemophilia-b-patients-us/ 2018-02-12T12:07:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-study-finds-far-uvc-light-can-kill-airborne-flu-virus/ 2018-02-12T15:09:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/delays-drug-approval-problems-teva/ 2018-02-09T16:56:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-gilead-hiv-patent-infringement/ 2018-02-09T16:43:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deliv-rx-offers-day-prescription-medicine-delivery/ 2018-02-09T13:54:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/biosimilar-threat-hangs-roches-oncology-portfolio/ 2018-02-09T11:23:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-optibiotix-health-cti-biopharma-novabay-pharmaceuticals/ 2018-02-09T10:23:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-zealand-researchers-develop-natural-remedy-diabetes/ 2018-02-09T10:11:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-fujifilm-develop-regenerative-medicine-therapies/ 2018-02-09T10:51:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/report-global-glaucoma-market-set-worth-3-8bn-2026/ 2018-02-09T10:29:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/brilinta-cardiac-events-heart-attack/ 2018-11-26T10:13:04+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/adocia-200m-damages-eli-lilly-partnership/ 2018-02-08T11:57:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/faecal-pills-next-cure-deadly-bowel-infections/ 2018-02-08T10:58:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chinas-dl-medicine-forms-research-alliance-pfizer/ 2018-02-08T11:14:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-obtains-second-fda-breakthrough-tag-meningitis-b-vaccine/ 2018-02-08T11:48:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-enters-drug-development-deal-theravance-biopharma/ 2018-02-08T11:21:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/innovation-prevent-return-pre-antibiotic-era/ 2018-02-07T16:55:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pill-alternative-injections-diabetes/ 2018-02-07T14:19:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-report-reveals-fewer-asthma-attacks-us-children/ 2018-02-07T12:12:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cancer-research-uk-study-anti-cancer-properties-aspirin/ 2018-02-07T10:59:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uks-icr-finds-new-combination-therapy-colon-cancer/ 2018-02-07T11:10:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/immune-checkpoint-inhibitors-dominate-cancer-immunotherapy-landscape/ 2018-02-06T15:18:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-agreement-collaboration-china/ 2018-02-06T15:08:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-sued-vaccine-death-philippines/ 2018-02-06T16:31:39+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/paige-ai-raises-25m-advance-cancer-diagnosis-treatment/ 2018-02-06T10:15:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-scientists-develop-new-hiv-vaccine-production-method/ 2022-12-02T14:27:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mncs-producing-unapproved-antibiotics-india-finds-new-uk-study/ 2018-02-06T10:26:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/world-cancer-day-2018-hold-cancer-research-treatment/ 2018-02-05T17:12:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/challenges-facing-european-contract-manufacturing-organizations/ 2018-02-05T13:13:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-breast-cancer-drug-nhs-england/ 2018-02-06T17:06:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/blockbuster-status-competition-intensifying-parp-inhibitors/ 2018-02-05T11:26:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-states-penalise-japanese-drug-firm-anti-competitive-tactics/ 2018-02-05T09:56:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/danish-researchers-create-new-approach-make-qr-coded-medicines/ 2018-02-05T12:02:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bcrf-us-expands-research-breast-cancer-treatment/ 2018-02-05T10:03:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nasal-spray-could-lower-risk-of-opioid-addiction/ 2018-02-02T16:52:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/biosimilars-surge-cmos-left-cold/ 2018-02-02T10:24:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alkermes-submits-nda-usfda-alks-5461-major-depressive-disorder/ 2018-02-04T16:42:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-sichuan-kelun-pharmaceutical-syros-pharmaceuticals-cerus/ 2018-02-02T09:51:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-concludes-703m-womens-health-products-deal-cvc-capital/ 2018-02-02T11:49:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/elsevier-adds-six-start-ups-pharma-innovation-hub/ 2018-02-02T10:36:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-guanhao-biotech-sanofi-grifols-shared-services-north-america/ 2018-02-02T10:00:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amazon-alliance-healthcare-costs/ 2018-02-01T17:18:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/corporate-heavyweights-tackle-healthcare/ 2018-02-01T16:13:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/urgent-action-needed-address-economic-challenges-facing-amr-rd/ 2018-02-01T13:06:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/explosive-biotech-ma-activity-early-2018/ 2018-02-01T12:02:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/sanofis-woes-dengue-continue-opening-door-rival-takeda/ 2018-02-01T11:18:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nih-launches-partnership-to-advance-parkinsons-disease-treatment/ 2018-02-01T09:44:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/seattle-genetics-buy-cascadian-therapeutics-614m/ 2018-02-01T11:13:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/shire-develop-ab-biosciences-platform-autoimmune-diseases/ 2018-02-01T11:17:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-biobank-offers-images-6000-subjects-medical-research/ 2023-02-23T05:37:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/novartis-commercialise-sparks-new-ophthalmology-gene-therapy/ 2018-01-31T16:40:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/roche-makes-headway-year-corporate-deals/ 2018-02-01T10:54:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/biogen-looks-boosts-pipeline-portfolio-following-record-revenue-reports/ 2018-01-31T14:56:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-canadian-initiative-reduce-generic-drug-prices/ 2018-01-31T11:13:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/su2c-us-launches-ai-based-immunotherapy-research-programme/ 2018-01-31T11:17:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/irish-researchers-say-new-technology-can-transform-pharma-market/ 2018-01-31T11:35:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/move-amsterdam-biggest-challenge-ema-ever-deal/ 2018-01-30T17:23:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/e-commerce-companies-allowed-sell-medicine/ 2018-01-30T14:23:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/slipper-limpet-slime-biotech-treasure-chest/ 2018-01-24T15:03:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/brexit-may-disrupt-medicines-supply-warns-british-alliance/ 2018-01-30T11:07:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roches-balovaptan-obtains-fda-breakthrough-therapy-designation/ 2023-01-19T05:43:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ablynx-enters-e3-9bn-acquisition-deal-sanofi/ 2018-01-30T11:12:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/developing-irresistible-cancer-treatments-can-done/ 2018-01-24T14:55:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-pharma-rd-pipeline-strongest-europe/ 2018-01-26T16:26:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-forms-alliance-otc-medicines-maker-unipharm/ 2018-01-29T10:56:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-lutathera-neuroendocrine-tumours/ 2018-01-29T10:42:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-pharma-lobbying-spend-surged-25-4m-2017/ 2018-01-26T12:12:01+00:00 daily 8.0 https://www.pharmaceutical-technology.com/comment/type-2-diabetes-drugs-headed-us-market-2018/ 2018-01-26T11:26:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/vbi-vaccines-pursues-future-hepatitis-b-vaccine-showdown-dynavax/ 2018-01-26T11:08:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/women-likely-develop-dry-eye-men/ 2023-05-23T03:55:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-shenzhen-salubris-pharmaceuticals-usv-sanofi/ 2018-01-25T12:01:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-torrent-pharmaceuticals-medico-remedies-shanghai-pharmaceutical/ 2018-01-25T12:06:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/synthons-syd985-fast-tracked-metastatic-breast-cancer/ 2018-01-26T10:16:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/amgen-novartis-edge-front-migraine-market/ 2018-01-25T15:40:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/court-ruling-crushes-jjs-hopes-zytigas-us-growth/ 2018-01-25T15:15:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-study-investigate-treatment-hiv-pregnant-women/ 2018-01-25T13:47:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-novartis-accused-anti-competitive-conduct-eu-court/ 2018-01-26T10:23:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/dundee-university-visiting-worlds-influential-pharmaceutical-research-institution/ 2018-01-24T14:38:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cardiome-pharma-receives-extended-indications-aggrastat-china/ 2018-01-25T10:15:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astellas-pharma-concludes-225m-mitobridge-acquisition/ 2018-01-25T10:19:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-issue-67/ 2023-04-12T06:05:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/beheard-rewarding-rare-disease-research/ 2018-01-24T14:33:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-transparency-clinical-trials/ 2022-07-11T08:56:27+00:00 daily 1.0 https://www.pharmaceutical-technology.com/comment/celgene-bets-heavily-car-t-revlimid-patent-looms/ 2018-01-24T11:02:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/oncology-digital-medicine-advances-2017/ 2018-01-24T10:59:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/time-europe-embrace-quadrivalent-influenza-vaccine/ 2018-01-25T14:18:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/hiv-generic-developing-world/ 2018-01-24T10:55:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biocryst-idera-sign-merger-agreement-rare-disease-drugs/ 2023-05-09T07:23:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/european-commission-authorises-adcetris-t-cell-lymphoma/ 2018-01-24T10:17:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/beating-polio-public-health-success-story/ 2018-01-23T16:42:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ai-robot-helps-discover-ingredient-anti-malarial-drug/ 2021-10-25T12:57:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/epilepsy-drug-sales-expected-drop-cagr-7-1/ 2018-01-23T15:16:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/use-parp-inhibitors-breast-cancer-will-vary-based-disease-subtype/ 2018-01-23T15:05:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/treatment-melanoma-approved-european/ 2023-02-03T08:55:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/shires-breakthrough-therapy-maribavir-potential-shake-cytomegalovirus-market/ 2018-01-23T12:12:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/hospital-owned-generics-boon-cmos-2/ 2018-01-23T10:18:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celgene-signs-9bn-acquisition-deal-juno-therapeutics/ 2018-01-23T10:06:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-offer-funding-new-medicine-manufacturing-centres/ 2018-01-23T10:11:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/biologics-biosimilars-nhs-move-makes-big-sense/ 2018-01-19T15:28:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-acquires-bioverativ-for-11-6bn/ 2018-01-26T10:43:34+00:00 daily 1.0 https://www.pharmaceutical-technology.com/comment/not-profit-hospitals-us-teaming-create-cheap-generic-drugs/ 2018-01-22T10:14:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-agrees-buy-bioverativ-11-6bn/ 2018-01-22T10:04:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-allergan-obtain-marketing-permit-mvasi-europe/ 2018-01-22T10:09:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/partnership-develop-haemophilia-gene-therapy/ 2018-01-22T16:13:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-expres2ion-biotech-holding-arbutus-biopharma-intrexon/ 2018-01-18T12:28:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-kymriah-wins-fast-review-dlbcl-us-europe/ 2018-01-19T09:32:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-approves-daratumumab-use-nhs-myeloma/ 2018-01-19T09:42:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/structure-of-anti-ageing-hormone-discovered/ 2018-01-25T13:59:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/breaking-cancers-drug-addiction/ 2018-01-18T11:28:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringers-gilotrif-receives-approval-egfr-mutation-positive-nsclc/ 2018-01-18T11:45:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-develop-oncology-drugs-cancer-research-uk-icr/ 2018-01-18T11:56:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-drug-regulation-brexit/ 2018-01-25T14:01:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/sanofi-regenerons-kevzara-faces-competition-rheumatoid-arthritis-market/ 2018-01-17T16:58:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/batavia-biosciences-joins-project-develop-new-polio-vaccine/ 2018-01-25T14:03:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sun-pharma-ironwood-allergan-settle-linzess-patent-litigation/ 2021-10-27T12:29:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fdas-mini-sentinel-finds-no-new-concerns-janssens-xarelto/ 2018-01-17T12:09:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accepts-sandozs-bla-biosimilar-adalimumab/ 2018-01-17T11:22:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/opioid-meds-no-longer-labelled-suitable-children/ 2023-05-31T05:25:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-lynparza-treat-inherited-breast-cancer/ 2023-01-04T12:29:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/helsinn-obtains-orphan-designation-pracinostat-treat-aml/ 2018-01-16T11:00:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/shires-haemophilia-drug-secures-eu-marketing-authorisation/ 2018-01-16T15:09:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/treating-heart-diseases-anti-inflammatories-biggest-breakthrough-since-statins/ 2018-01-15T17:31:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/targeted-therapeutics-made-possible-development-computer-logic-controlled-biomaterials/ 2018-01-16T09:38:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/dupixent-establishing-premier-dermatology-treatment/ 2018-01-15T12:45:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nanobiotix-conduct-pancreatic-cancer-research-nbtxr3/ 2018-01-15T10:21:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-builds-new-oral-solid-dose-production-facility-china/ 2018-01-15T10:31:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pfizer-boosts-uc-presence-approval-second-remicade-biosimilar/ 2018-01-12T13:05:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/epilepsy-drug-sales-hit-7-5bn-2026/ 2018-01-12T11:02:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/billion-dollar-deals-mean-bright-future-takeda/ 2018-01-12T10:24:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/european-commission-approves-astrazenecas-fasenra-asthma/ 2018-01-12T10:31:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-cspc-nbp-pharmaceutical-international-finance-corporation-sun-pharmaceutical/ 2018-01-12T10:05:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-melinta-therapeutics-cipher-pharmaceuticals-baxter-international/ 2018-01-12T10:13:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/japans-heptares-joins-imperial-college-london-drug-rd/ 2018-01-12T10:40:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/texas-research-finds-new-way-improve-brain-cancer-therapy/ 2018-01-12T11:54:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/easy-swallow-rapid-growth-smart-pill-market-expected-2025/ 2018-01-25T14:03:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/doe-shires-restructuring-foreshadow-neuroscience-spin-off-divesture/ 2018-01-11T10:05:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/celgene-set-challenge-incyte-novartis-myelofibrosis-landscape/ 2018-01-15T10:04:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/mdma-become-psychiatrys-antibiotic/ 2018-01-10T14:16:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-supply-beigenes-tislelizumab-china/ 2021-10-25T09:25:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/syapse-roche-bolster-precision-medicine-cancer/ 2018-01-11T10:23:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rhythm-pharma-uses-wuxis-ai-obesity-disorder-therapy/ 2018-01-11T10:32:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/needleless-injections-used-in-zika-vaccine/ 2018-01-19T16:10:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/uncertain-times-brexit-effect-pharma/ 2018-01-10T13:00:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-agrees-review-mercks-ndas-hiv-drug-doravirine/ 2018-01-10T09:42:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regeneron-forms-consortium-advance-human-gene-sequencing/ 2018-01-10T09:59:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-alder-sign-global-licence-agreement-anti-cgrp-therapy/ 2018-01-10T11:54:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-plans-acquire-tigenix-e520m/ 2018-01-09T09:50:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-alnylam-restructure-rnai-rare-disease-alliance/ 2018-01-09T09:56:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ablynx-rejects-novo-nordisks-acquisition-proposal/ 2018-01-09T11:51:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/beacon-enters-drug-discovery-collaboration-janssen/ 2018-01-08T10:15:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-grants-fast-track-designation-malaria-drug-tafenoquine/ 2018-01-08T10:21:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celgene-purchase-impact-biomedicines-1-1bn-upfront/ 2018-01-08T13:12:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/venture-financing-biotech-firms-continues-growth-trend/ 2018-01-05T14:44:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/us-pharma-industry-holds-price-cap-pledge/ 2018-01-11T10:07:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/glaucoma-market-ten-year-forecast/ 2023-04-14T06:18:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-shenzhou-yiqiao-information-service-walvax-biotechnology-kangmei-pharmaceutical/ 2018-01-08T07:52:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/icr-study-finds-virus-potential-brain-tumour-treatment/ 2018-01-05T10:45:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-awards-breakthrough-designation-novartis-promacta/ 2018-01-05T10:36:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-orbimed-asia-partners-kadmon-holdings-ani-pharmaceuticals/ 2018-01-05T09:50:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/servier-treventis-develop-drugs-alzheimers-disease/ 2018-01-09T09:25:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/apollobio-develop-inovios-vgx-3100-greater-china/ 2018-01-04T10:15:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-sangamo-develop-zinc-finger-protein-therapy-als/ 2018-01-04T12:13:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accepts-sbla-seattle-genetics-adcetris-hodgkin-lymphoma/ 2018-01-04T10:28:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/2017-sees-fewest-first-time-indications-awarded-fda-orphan-drug-designation-since-2009/ 2018-01-03T16:45:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/key-biotechnology-drivers-2018-will-surge-continue/ 2018-01-04T11:29:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/seysara-set-boost-stagnant-treatment-landscape-acne/ 2023-05-17T05:12:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/hiv-traditional-small-molecules-new-biologics/ 2018-01-03T11:45:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biocon-mylans-biosimilar-receives-brazilian-regulatory-approval/ 2018-01-03T11:13:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-faces-lawsuits-knee-amputations-due-invokana/ 2018-01-03T12:39:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ani-pharma-purchases-us-rights-four-astrazeneca-products/ 2018-01-03T11:23:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mallinckrodt-agrees-buy-sucampo-pharma-1-2bn/ 2018-01-02T11:49:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-pharmaceutical-launches-generic-version-reyataz-us/ 2018-01-09T12:12:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accepts-nda-filing-gw-pharmaceuticals-epidiolex/ 2018-01-02T11:15:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/2017-biggest-news-stories-pharmaceutical/ 2018-01-04T11:34:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/seasons-greetings/ 2017-12-22T11:02:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayers-partner-loxo-oncology-initiates-nda-larotrectinib/ 2017-12-22T10:46:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-agrees-manufacture-viral-vectors-bluebird-bio/ 2017-12-22T10:38:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-china-meheco-recordati-novartis/ 2017-12-22T10:22:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-strides-pharma-asia-glaxosmithkline/ 2017-12-22T10:32:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-issue-66/ 2023-04-12T06:21:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/look-bayers-top-performing-drugs/ 2017-12-21T13:41:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/look-astrazenecas-top-performing-drugs/ 2017-12-21T13:39:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/look-amgens-top-performing-drugs/ 2018-01-03T11:40:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/look-takedas-top-performing-drugs/ 2017-12-21T13:32:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-partners-uks-autifony-cns-therapeutics/ 2017-12-21T11:06:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-spark-therapeutics-luxturna-retinal-dystrophy/ 2017-12-21T11:02:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dice-genentech-enter-multi-year-research-collaboration/ 2018-01-09T09:35:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/oncology-strategic-alliances-q4-2017-focus-deals-organisations-heterogeneous-nature/ 2023-01-05T06:05:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-scientists-find-arthritis-treatment-effective-skin-cancer/ 2017-12-20T11:59:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/avista-pharma-completes-facility-upgrades-longmont-site-us/ 2017-12-20T12:06:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/otsuka-x-chem-advance-discovery-process-drug-compounds/ 2021-10-28T12:24:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/brexits-implications-uk-pharmaceutical-sector/ 2017-12-19T12:05:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regeneron-isa-pharma-advance-immunotherapy-combination/ 2017-12-19T11:02:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cpnps-cellprotect-receives-orphan-drug-designation-ec/ 2017-12-19T11:17:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-publishes-two-draft-guidances-developing-targeted-therapies/ 2017-12-19T11:14:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/removing-barriers-data-sharing-pharmaceutical-rd/ 2017-12-15T11:54:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-unveils-restructuring-plan-improve-productivity/ 2017-12-18T09:54:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/emas-chmp-recommends-novo-nordisks-ozempic-diabetes/ 2017-12-19T13:13:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/crt-celgene-sign-drug-discovery-collaboration/ 2017-12-18T10:57:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/dbvs-viaskin-peanut-still-viable-despite-phase-iii-failure/ 2017-12-15T11:13:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-zealand-researchers-find-new-treatment-babies-born-small/ 2017-12-15T15:18:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/report-multiple-sclerosis-disease-modifying-therapies-market-witness-cagr-2-9/ 2017-12-15T11:37:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-shanghai-shyndec-pharmaceutical-aprecia-pharmaceuticals-daiichi-sankyo-company/ 2017-12-15T12:13:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-acquires-fda-approval-new-biosimilar-ixifi/ 2017-12-15T15:25:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/germanys-evotec-crtd-find-new-therapies-retinal-diseases/ 2023-03-30T07:38:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-allergan-philab-holdings/ 2017-12-15T11:30:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-acquires-exclusive-licence-ono-pharmas-anti-tumour-candidate/ 2017-12-14T15:12:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daiichi-sankyo-puma-biotech-assess-combination-cancer-therapy/ 2017-12-14T11:59:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-gsks-drug-eosinophilic-granulomatosis-polyangiitis/ 2017-12-14T12:07:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/gene-silencing-therapy-offers-hope-huntingtons-disease/ 2023-05-09T06:41:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/artificial-intelligence-2018-27-predictions-business/ 2018-01-05T16:55:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/discontinuation-sanofis-c-difficile-vaccine-program-spell-good-news/ 2023-01-23T12:53:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/migraine-treatment-become-less-headache-revolutionary-new-solutions/ 2017-12-13T13:00:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-nih-funded-consortium-expand-trials-alzheimers/ 2017-12-13T10:09:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/northsea-therapeutics-secures-funding-develop-nash-drug/ 2023-05-17T05:01:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofis-short-acting-insulin-admelog-wins-fda-approval/ 2017-12-13T10:17:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/blame-game-pharma-trial-us-opioid-crisis/ 2023-01-17T09:56:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-recommends-eisais-kisplyx-renal-cell-carcinoma/ 2022-09-09T11:46:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/synlogic-ginkgo-bioworks-enter-drug-discovery-partnership/ 2017-12-12T11:32:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accepts-bla-eli-lillys-galcanezumab-treat-migraine/ 2017-12-12T13:53:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/bringing-nhs-pharma-closer-together/ 2017-12-08T11:54:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-take-cell-design-labs-567m/ 2017-12-11T10:59:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-scientists-find-potential-therapy-ebola-virus-infection/ 2017-12-11T11:06:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/meiragtx-obtains-rare-disease-designation-gene-therapy-a001/ 2017-12-11T13:21:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/psoriatic-arthritis-will-eli-lillys-taltz-perform-novartiss-cosentyx/ 2017-12-08T09:44:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bluebird-bio-tc-biopharm-develop-new-cancer-immunotherapies/ 2017-12-08T12:26:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/icr-scientists-find-new-target-protein-cancer/ 2017-12-08T12:11:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-revance-therapeutics-gw-pharmaceuticals-valeant-pharmaceuticals-international/ 2017-12-07T21:33:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/carmot-amgen-identify-new-therapeutics-parkinsons/ 2017-12-08T12:17:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-cvs-health-corporation-neurosearch/ 2017-12-07T21:38:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/neurologists-additional-pml-cases-ms-not-major-concern-ocrevus/ 2017-12-13T10:19:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/jjs-darzalex-set-shake-frontline-treatment-multiple-myeloma/ 2017-12-07T11:50:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/new-approach-treating-schizophrenia/ 2017-12-07T10:20:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-life-sciences-industry-secures-government-sector-deal/ 2017-12-07T13:19:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/everest-offer-two-arena-pharma-drugs-asian-countries/ 2017-12-07T11:46:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-fda-approves-genentechs-avastin-glioblastoma/ 2017-12-07T11:43:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/the-impact-of-medicare-coverage-for-anti-obesity-interventions-html/ 2021-11-02T03:27:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/new-drug-harness-gut-bacteria-end-lactose-intolerance/ 2017-12-06T15:03:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/chinas-new-regulations-set-stage-partnerships-acquisitions/ 2021-11-22T08:16:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/accc-sues-novartis-gsk-false-marketing-voltaren-products/ 2017-12-06T12:33:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novembers-top-news-stories-2017/ 2022-08-17T11:26:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-launches-100m-initiative-address-hiv/ 2017-12-06T11:10:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/blue-oak-psychogenics-develop-new-brain-disorder-therapies/ 2023-08-11T04:03:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-astho-seeks-1bn-funding-opioid-epidemic/ 2017-12-05T12:57:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayer-extends-research-collaboration-cancer-treatments/ 2017-12-05T11:24:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-acquires-licensing-rights-basileas-cresemba-china/ 2017-12-05T11:34:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/delivery-destination-mapping-nanoparticles-poor-sense-direction/ 2017-12-04T15:00:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/forecast-top-10-best-selling-drugs-oncology-2023/ 2017-12-04T12:02:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cvs-health-take-aetna-69bn/ 2017-12-04T12:06:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-accepts-marketing-application-trastuzumab-pegfilgrastim/ 2017-12-04T09:05:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astellas-acquires-drug-discovery-subsidiary-mitobridge/ 2017-12-04T09:00:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/national-academies-report-adds-fuel-to-fire-in-raging-us-drug-pricing-debates-html/ 2021-11-02T03:27:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cancer-genetics-icon-reduce-cancer-mortality-rate-india/ 2021-10-29T08:48:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-kaisa-group-holdings-zhongyuan-union-cell-gene-engineering/ 2017-12-01T12:17:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-grants-orphan-drug-status-shires-uc-treatment-shp647/ 2017-12-01T13:57:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-xiangxue-pharmaceutical-astrazeneca-vanc-pharmaceuticals/ 2017-12-01T10:31:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/portugal-researcher-create-3d-cancer-disease-models/ 2017-12-01T13:50:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/lifnano-can-nanotech-flip-switch-cure-multiple-sclerosis/ 2020-01-31T13:44:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/evocalcet-faces-stiff-competition-japans-ckd-induced-hyperparathyroidism-market/ 2017-11-30T10:38:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pharmaceutical-ma-deals-decline/ 2017-11-30T10:26:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-validates-bms-application-widen-cancer-therapy-indication/ 2017-11-30T14:15:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazenecas-regulatory-submission-accepted-tagrisso/ 2017-11-30T12:16:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-seeks-fda-approval-tafenoquine-treat-p-vivax-malaria/ 2017-11-30T12:20:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/boehringer-gains-ema-approval-cyltezo-eus-third-humira-biosimilar/ 2017-11-29T15:25:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/red-sage-ancient-chinese-herb-prevent-bone-loss/ 2023-01-04T11:12:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sobi-receives-approval-orfadin-treat-ht-1-patients-canada/ 2017-11-29T10:44:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-fda-grants-fast-track-status-stealths-elamipretide/ 2017-11-29T14:43:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bioge-alkermes-develop-alks-8700-ms-treatment/ 2017-11-29T15:00:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/diy-medicines-anarchic-fringe-drug-price-debate/ 2017-11-28T16:01:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hitgen-identify-new-small-molecule-leads-boehringer/ 2017-11-28T11:36:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharming-submits-application-fda-ruconest-treat-hae/ 2023-03-31T10:38:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-submit-cdf-proposal-cancer-drug/ 2017-11-28T13:38:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/amsterdam-triumphs-is-the-netherlands-a-trojan-horse-for-pricing-and-drug-approval-reform-in-europe-html/ 2021-11-02T03:27:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/shingrix-effective-shingles-vaccine-huge-commercial-promise/ 2017-11-27T11:18:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-innoviva-file-snda-expanded-scope-trelegy-ellipta/ 2017-11-27T12:32:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/specialised-therapeutics-commercialise-pumas-nerlynx-breast-cancer/ 2017-11-27T11:57:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/acerus-grants-apsen-rights-market-natesto-brazil/ 2017-11-27T15:02:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/beactica-advance-lsd1-programme-glioblastoma-treatment/ 2017-11-24T12:05:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-eris-lifesciences-sichuan-languang-development-xiangxue-pharmaceutical-navamedic/ 2017-11-24T10:26:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-launches-tremfya-uk-treat-psoriasis/ 2017-11-24T12:10:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/report-singapores-pharmaceutical-market-witness-5-cagr-2021/ 2017-11-24T10:18:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-caligor-rx-zhejiang-jolly-pharmaceutical/ 2017-11-24T10:08:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/trackable-pills-big-benefits-big-brother/ 2017-11-23T11:24:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lead-pharma-sanofi-collaboration-autoimmune-diseases-achieves-third-milestone/ 2017-11-23T10:21:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-fda-approves-viiv-healthcares-juluca-regimen-treat-hiv-1/ 2017-11-23T12:09:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/study-finds-cellular-mechanisms-promote-pancreatitis-pancreatic-cancer/ 2023-06-09T07:34:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/inside-carb-x-can-new-model-research-fix-broken-antibiotic-market/ 2017-11-22T17:47:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tesaros-zejula-receives-ec-approval-treat-ovarian-cancer-europe/ 2017-11-22T11:48:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/study-finds-gastric-treatment-lansoprazole-may-target-tuberculosis/ 2017-11-22T12:00:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-cma-accuses-concordia-overcharging-nhs-thyroid-drug/ 2017-11-22T12:06:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/can-uk-stay-medicines-cutting-edge/ 2017-11-21T13:35:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/tax-reform-bill-puts-us-orphan-drug-act-threat/ 2017-11-21T11:45:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pharma-rd-adapting-personalised-future/ 2017-11-21T16:16:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-nccn-fund-new-projects-improve-breast-cancer-care/ 2017-11-21T10:24:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/samsung-bioepis-ontruzant-acquires-marketing-rights-cancer-europe/ 2017-11-21T10:53:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/study-finds-benzodiazepine-increases-mortality-alzheimers-patients/ 2022-07-11T08:56:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/nutraceuticals-held-back-regulatory-confusion/ 2017-11-20T15:37:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/acne-treatment-doxycyclines-side-effects-outweigh-benefits/ 2024-05-10T06:39:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bb2121-receives-ema-prime-eligibility-fda-btd-multiple-myeloma/ 2017-11-20T09:56:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-enzyme-identified-cuts-amino-acid-tyrosine-off-cytoskeleton/ 2017-11-20T10:31:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cue-biopharma-merck-develop-biologics-autoimmune-diseases/ 2017-11-20T11:17:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-shanghai-pharmaceutical-sapphire-hk-holdings-sumitomo-corporation-america/ 2021-11-30T11:45:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazenecas-faslodex-verzenio-receives-fda-approval-advanced-breast-cancer/ 2017-11-17T11:11:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accepts-filing-alkermes-nda-schizophrenia-treatment/ 2017-11-17T11:17:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-valeant-pharmaceuticals-international-hikma-pharmaceuticals-yabao-pharmaceutical-group/ 2017-11-17T10:22:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/report-venezuelas-economic-crisis-hit-domestic-pharmaceutical-market/ 2017-11-17T10:30:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/support-use-inflectra-crohns-disease/ 2017-11-16T14:57:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/redefining-high-blood-pressure-ease-long-term-effects/ 2017-11-20T10:10:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/global-gene-osuccc-james-boost-cancer-research-south-asia/ 2017-11-16T12:06:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/shires-adynovi-receives-chmp-positive-opinion-haemophilia/ 2017-11-16T10:31:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-recommends-pfizers-palbociclib-treat-advanced-breast-cancer/ 2017-11-16T12:05:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-issue-65/ 2023-04-12T06:15:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/icer-nice-different/ 2017-11-15T11:15:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/juno-therapeutics-explores-car-t-trial-deaths/ 2022-07-11T08:56:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/mycite-first-pill-digital-tracking-system/ 2017-11-15T09:45:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/loxo-oncology-bayer-co-develop-cancer-drugs-1-55bn-deal/ 2017-11-15T11:51:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/european-commission-approves-gsks-benlysta-treat-sle-patients/ 2017-11-15T11:42:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/shanghai-pharma-buy-cardinal-health-china-business-1-2bn/ 2017-11-15T11:31:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pakistans-punjab-province-launch-novartis-access-treatments/ 2017-11-14T10:32:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-award-launched-support-ai-based-medical-research-uk/ 2017-11-14T10:38:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-idf-partner-support-global-type-2-diabetes-prevention/ 2017-11-14T10:45:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/will-argentinas-public-healthcare-reform-finally-accelerate-html/ 2021-11-02T03:29:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/rocking-us-generics-boat-indian-competition-fda-pressure/ 2021-12-02T05:07:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aquila-support-macrophages-immuno-oncology-programme/ 2023-06-30T04:32:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-fda-approves-mercks-prevymis-tablets/ 2017-11-13T11:21:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/value-in-healthcare-insights-from-ispor-html/ 2021-11-02T03:29:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-develop-principias-btk-inhibitor-multiple-sclerosis/ 2021-11-25T10:51:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cerenis-therapeutics-acquire-lypro-biosciences-assets/ 2017-11-10T13:36:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-egyptian-american-enterprise-fund-valeant-pharmaceuticals-international/ 2017-11-10T11:04:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-sarepta-therapeutics-cumberland-pharmaceuticals-cti-biopharma/ 2017-11-10T11:07:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/marking-milestones-north-american-cystic-fibrosis-conference-2017/ 2017-11-09T10:37:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/cystic-fibrosis-matching-medicines-mutations/ 2017-11-09T10:04:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-mina-develop-new-compounds-nash-disease/ 2017-11-09T10:50:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/spark-therapeutics-pfizer-amend-agreement-spk-9001-therapy/ 2017-11-09T11:16:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/better-diabetes-treatment-can-save-medicaid-over-4-billion-per-year-html/ 2021-11-02T03:29:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/octobers-top-stories-nih-found-new-target-proteins-anti-malaria-drugs-nci-discovered-new-way-combat-cancer/ 2017-11-10T17:12:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oxford-biodynamics-us-firm-advance-new-treatment-fibrosis/ 2017-11-08T11:40:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-submits-maa-ctl019-immunocellular-therapy/ 2017-11-08T11:45:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/vyzulta-approval-opens-new-avenues-glaucoma-treatment/ 2023-07-24T13:09:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-fda-approves-genentechs-zelboraf-treat-ecd/ 2017-11-07T10:58:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-grant-awarded-support-leukaemia-research-us/ 2017-11-07T11:10:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/metabolic-disorders-market-heavily-dominated-diabetes-drugs/ 2023-05-09T08:02:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/viivs-fostemsavir-positioned-treatment-resistant-hiv-patients/ 2022-07-11T08:56:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mallinckrodt-acquire-ocera-therapeutics-117m/ 2017-11-06T11:52:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/__trashed-3/ 2017-11-06T12:09:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/top-five-drivers-cardiovascular-market-growth/ 2017-11-03T15:13:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-hildred-capital-partners-novartis-neos-therapeutics/ 2017-11-03T12:09:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-xiangxue-pharmaceutical-sumitomo-dainippon-pharma-zhongzhi-pharmaceutical-holdings/ 2017-11-03T11:58:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bausch-lomb-receives-fda-approval-vyzulta/ 2023-04-14T09:13:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-amgen-bai-partner-ad-prevention-programme/ 2017-11-03T11:11:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/was-this-worth-the-wait-the-uk-government-responds-to-last-years-accelerated-access-review-html/ 2021-11-02T03:30:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/first-gene-therapies-cns-diseases-horizon/ 2017-11-02T17:13:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/number-pipeline-drugs-us-therapy-area/ 2017-11-02T16:18:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/top-10-pharma-companies-prescription-drug-sales-2016-vs-2015/ 2017-11-02T15:52:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/amgens-parsabiv-helps-treatment-ckd-induced-hyperparathyroidism/ 2017-11-02T15:05:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-recommends-roches-atezolizumab-via-cdf-bladder-cancer/ 2017-11-02T11:51:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogeneration-ventures-closes-third-fund-bgv-iii-e82m/ 2017-11-02T12:08:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ono-pharmaceutical-shows-strength-strategic-alliance-deals/ 2021-11-23T11:35:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/tackling-americas-opioid-addiction/ 2017-11-01T11:50:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/fierce-competition-amongst-checkpoint-inhibitor-developers/ 2021-10-27T10:42:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/gileads-kite-pharma-acquisition-leads-q3-2017-deals/ 2017-11-01T10:55:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/celgene-scraps-crohns-phase-iii-trial-mongersen-ozanimod-continues-show-good-results/ 2022-07-11T08:56:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/good-news-janssens-symtuza-positive-top-line-results-announced-amber-trial/ 2022-07-11T08:56:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/2017-fda-approvals-show-oncology-strength/ 2017-11-01T11:03:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mit-researcher-develops-new-nutrient-mix-treat-early-stages-alzheimers/ 2017-11-01T12:00:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-sells-rights-neutrophil-elastase-inhibitor-mereo/ 2017-11-01T11:49:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/visit-us-at-ispor-2017-glasgow-html/ 2021-11-02T03:30:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/blockchain-pharma-opportunities-supply-chain/ 2023-02-06T07:12:29+00:00 daily 3.0 https://www.pharmaceutical-technology.com/news/australian-government-offers-100m-fund-brain-cancer-research/ 2017-10-31T10:37:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accepts-bla-bayers-bay94-9027-treat-haemophilia/ 2017-10-31T14:28:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/fda-approves-first-gmg-treatment-60-years/ 2023-01-19T06:13:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/drug-expiration-dates-fit-purpose/ 2017-10-26T14:15:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-fda-grants-priority-review-abbvies-elagolix-endometriosis/ 2023-06-15T04:08:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-public-private-consortium-accelerate-discovery-cancer-therapies/ 2017-10-30T13:00:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nih-finds-new-target-proteins-anti-malaria-drugs/ 2017-10-30T10:13:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-northwind-pharmaceuticals-anhui-anke-biotechnology/ 2021-10-22T07:46:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-alimera-sciences-thrombogenics-abbvie/ 2021-11-22T10:29:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/saudi-fda-approves-sobis-alprolix-haemophilia-b/ 2021-12-02T05:57:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alkermes-submits-nda-fda-alncd-initiate-onto-schizophrenia-drug/ 2021-12-01T13:20:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/avanir-investigated-aggressive-marketing/ 2017-10-26T16:00:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/poor-life-cycle-management-easiest-way-pharma-companies-lose-billions/ 2021-11-02T06:10:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/second-line-chemotherapy-options-advanced-pancreatic-cancer/ 2022-01-24T13:33:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/inside-norpd-norways-treasure-trove-prescription-data/ 2017-10-26T10:41:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/hemophilia-b-gene-therapy-race-heats-following-fitusirans-failure/ 2021-11-22T09:27:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-government-offers-new-funding-life-sciences-sector/ 2017-10-26T10:36:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-researcher-identifies-new-pain-regimen-breast-cancer-patients/ 2017-10-26T10:30:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuniversity-of-strathclyde-researchers-study-new-way-to-prevent-alzheimers-5956361/ 2017-10-26T10:13:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspharmexcil-forecasts-indias-generics-exports-growing-at-22-per-year-5956355/ 2017-10-26T10:11:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsamgen-simcere-partner-to-develop-and-commercialise-biosimilars-in-china-5936455/ 2019-03-01T14:08:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-orphan-designation-to-tigenixs-cx601-for-crohns-disease-5955103/ 2017-10-27T11:13:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbrazils-biolab-pharma-selects-ontario-for-its-first-international-facility-5955098/ 2017-10-26T09:19:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsabbvies-hepatitis-c-drug-recommended-for-use-within-uk-nhs-wales-5954210/ 2021-11-22T06:53:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsimprimis-offer-low-cost-alternative-restasis-dry-eye-disease-5954220/ 2023-03-27T13:33:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/chinas-new-clinical-trial-regulations-a-win-win-for-all-html/ 2021-11-02T03:30:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cern-medicis-backing-nuclear-medicine/ 2017-10-26T14:49:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/report-indonesian-pharmaceutical-market-worth-10-11bn-2021/ 2023-05-30T03:51:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-wuxi-apptec-cachet-pharmaceutical-shenzhen-neptunus-bioengineering/ 2021-11-22T09:31:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-harbin-gloria-pharmaceuticals-f-hoffmann-la-roche-intrexon/ 2021-11-30T11:39:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsshanghai-pharma-provides-update-on-reports-about-cardinal-health-deal-5953066/ 2017-10-25T09:55:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsteva-submits-bla-for-fremanezumab-to-fda-for-migraine-prevention-5952387/ 2017-10-24T12:21:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-and-plasticell-to-manufacture-haematopoietic-cells-from-ipsc-5952391/ 2017-10-24T12:23:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstakeda-and-hemoshear-partner-to-discover-new-treatments-for-liver-diseases-5952390/ 2017-10-24T12:23:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-issue-64/ 2023-04-12T06:11:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-priority-review-for-exelixis-cabometyx-to-treat-advanced-rcc-5951164/ 2021-12-02T09:43:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsamgen-and-boston-childrens-hospital-to-identify-new-targets-for-pain-syndromes-5951207/ 2017-10-24T12:24:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmutabilis-joins-european-enable-project-develop-new-antibiotics-5951224/ 2017-10-24T12:24:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/time-for-a-consultation-on-the-impact-of-brexit-on-the-uks-access-to-medicines-better-late-than-never-html/ 2021-11-02T03:30:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newswarp-drive-and-roche-collaborate-to-develop-new-classes-of-antibiotics-5950541/ 2017-10-24T12:25:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgenomics-and-biogen-partner-to-discover-new-multiple-sclerosis-treatments-5950454/ 2017-10-24T12:25:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazenecas-faslodex-receives-chmp-opinion-for-advanced-breast-cancer-treatment-5950385/ 2017-10-24T12:26:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsshires-lyophilised-oncaspar-receives-positive-chmp-opinion-for-all-in-europe-5949665/ 2017-10-24T12:27:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsks-shingrix-receives-approval-in-canada-to-prevent-shingles-5949678/ 2017-10-24T12:27:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/new-import-substitution-initiatives-in-the-middle-east-2017-the-year-of-new-policies-html/ 2021-11-02T03:30:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-nih-launches-215m-partnership-for-accelerating-cancer-therapies-5949916/ 2017-10-25T08:59:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/researchreportreport-alzheimers-market-set-to-achieve-double-digit-growth-by-2026-5947117/ 2017-10-20T11:48:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-catalent-pharma-solutions-china-grand-pharmaceutical-and-healthcare-holdings-recursion-pharmaceuticals-5946900/ 2021-10-27T10:55:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-first-coin-capital-china-grand-pharmaceutical-and-healthcare-holdings-tael-management-5946913/ 2017-10-20T10:46:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurehard-nut-to-crack-new-trial-brings-new-hope-for-children-with-peanut-allergies-5920358/ 2017-11-28T16:40:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentwith-fda-approval-secured-flexions-zilretta-poised-to-shake-up-knee-osteoarthritis-marketplace-5947301/ 2017-10-13T11:17:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjanssen-biotech-submits-nda-to-fda-for-apalutamide-to-treat-non-metastatic-crpc-5946930/ 2017-10-24T12:28:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdaiichi-sankyo-astellas-and-mitsubishi-tanabe-partner-to-develop-new-therapeutics-5946496/ 2017-10-24T12:28:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsabbvie-obtains-licence-for-turnstone-biologics-oncolytic-viral-immunotherapies-5946376/ 2017-10-24T12:28:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspistoia-alliance-to-develop-elsevier-unified-data-model-5945709/ 2017-10-24T12:30:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssmc-approves-daratumumab-for-myeloma-patients-in-scotland-5945135/ 2022-07-11T08:56:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newshealth-canada-accepts-marketing-application-for-mithras-hormone-therapy-tibelia-5945280/ 2021-11-22T13:04:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentbig-pharma-fails-to-challenge-uk-price-controls-as-court-backs-nice-5944941/ 2017-10-20T14:46:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsema-accepts-marketing-application-for-imfinzi-to-treat-nsclc-patients-5944226/ 2017-10-24T12:13:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspiramal-to-expand-in-api-manufacturing-capabilities-with-55m-5944848/ 2017-10-24T12:14:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-approves-flexions-zilretta-to-treat-osteoarthritis-knee-pain-5944185/ 2017-10-24T12:11:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsresearchers-use-supercomputing-cancer-drugs-discovery-5943007/ 2017-10-24T14:38:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseuropean-commission-grants-orphan-drug-status-to-apogenixs-asunercept-for-mds-5943497/ 2017-10-24T14:21:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsavara-pharmaceutical-buys-astrazenecas-reims-solid-dosage-facility-5943647/ 2017-10-24T14:14:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnetherlands-cancer-institute-discovers-new-way-to-fight-cancer-5941782/ 2017-10-24T16:42:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssynthons-generic-version-of-copaxone-40mg-receives-european-approval-to-treat-ms-5941824/ 2017-10-24T14:42:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentfda-gave-mylans-copaxone-generic-the-green-light-5943165/ 2017-10-13T11:13:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureseptember-2017-top-news-stories-pharmaceutical-5943052/ 2017-10-13T10:48:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurehow-voice-assistant-technology-could-revolutionise-clinical-trials-5921153/ 2022-07-11T08:56:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentrepealing-the-aca-the-graham-cassidy-bills-impact-on-expanded-medicaid-coverage-5940881/ 2017-10-13T11:09:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-breakthrough-therapy-designation-for-new-hodgkin-lymphoma-therapy-5939237/ 2017-10-24T14:43:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstransgene-randox-partner-to-develop-oncolytic-immunotherapies-for-solid-tumours-5939258/ 2022-11-16T13:57:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-grants-priority-review-status-to-allergans-snda-for-avycaz-5939655/ 2017-10-24T14:31:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentcan-jjs-sirukumab-survive-fda-rejection-5939215/ 2017-10-20T14:52:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-recommends-use-of-janssens-imbruvica-for-waldenstrms-macroglobulinaemia-5938627/ 2022-08-02T10:44:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmylan-launches-generic-version-of-gleevec-tablets-in-us-5938685/ 2017-10-24T14:49:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/safety-concerns-cloud-ocalivas-future-prospects-nash/ 2022-11-24T12:16:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsks-benlysta-receives-japanese-mhlw-approval-for-systemic-lupus-erythematosus-5937584/ 2019-03-01T14:09:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsec-grants-marketing-authorisation-for-sanofi-and-regenerons-dupixent-for-ad-5937593/ 2019-03-01T14:09:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentover-two-thirds-of-women-unaware-of-sodium-valproate-safety-risks-5938642/ 2017-10-13T11:02:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentgsk-announces-planned-regulatory-filing-of-nucala-will-the-il-5-inhibitor-mark-the-first-approved-biologic-for-copd-5938662/ 2017-10-13T11:00:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-global-migraine-market-forecast-to-reach-87bn-by-2026-5936207/ 2017-10-24T10:21:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsabbvies-maviret-receives-japanese-mhlw-approval-to-treat-hcv-5935729/ 2017-10-24T14:38:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-accepts-to-review-eisais-application-for-lenvima-to-treat-hcc-5936528/ 2019-03-01T14:10:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentgreen-pharma-the-growing-demand-for-environmentally-friendly-drugs-5937344/ 2022-02-14T10:58:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/international-referemce-pricing-expands-reach-in-leading-latin-american-countries-html/ 2021-11-02T03:30:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmithra-libbs-sign-agreement-for-commercialisation-of-estelle-oral-contraceptive-in-brazil-5934470/ 2021-11-22T13:05:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseuropean-commission-approves-janssens-symtuza-for-hiv-1-treatment-5935385/ 2017-10-24T14:26:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsboehringer-geisinger-partner-to-develop-a-risk-prediction-model-for-type-2-diabetes-health-outcomes-5935590/ 2017-10-24T14:34:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentis-the-neulasta-molecule-too-complex-for-biosimilar-developers-to-crack-5935195/ 2017-09-26T06:53:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsallergan-gets-fdas-rtf-letter-for-vraylar-drug-application-to-treat-schizophrenia-5933838/ 2021-11-30T11:36:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscfda-approves-gileads-sovaldi-for-chronic-hepatitis-c-treatment-5934312/ 2017-09-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-the-max-foundation-to-provide-cancer-access-program-in-lower-income-countries-5934407/ 2017-09-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportrisk-of-sepsis-is-higher-in-an-older-population-5933471/ 2017-09-25T04:28:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseuropean-commission-approves-roches-tocilizumab-to-treat-giant-cell-arteritis-5932380/ 2023-05-19T03:11:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsoncoqrs-s-tir-vaccine-technology-induces-killing-of-cancer-cells-5932736/ 2017-09-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmercks-keytruda-gets-accelerated-fda-approval-for-gej-adenocarcinoma-5933222/ 2022-02-14T07:14:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-aspen-global-incorporated-zhejiang-conba-pharmaceutical-teva-pharmaceutical-industries-5930775/ 2017-09-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-catalent-ultragenyx-pharmaceutical-5930779/ 2017-09-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-multiple-pipeline-products-to-drive-growth-of-healthcare-associated-infections-market-5931054/ 2017-09-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-rydapt-receives-approval-for-two-cancer-treatments-in-the-eu-5931569/ 2017-09-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-joins-astrazeneca-to-use-labcytes-acoustic-technology-to-develop-mass-spectrometry-5931620/ 2017-09-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportthe-us-and-the-uk-see-a-high-percentage-of-cdt-cdi-cases-5931255/ 2017-09-21T04:42:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-recommends-bristol-myers-squibbs-nivolumab-for-nsclc-patients-on-nhs-5930408/ 2017-09-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsrecipharm-roche-sign-agreement-to-manufacture-solid-dose-products-5930718/ 2017-09-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-files-suit-against-johnson-johnson-for-healthy-biologics-competition-5930952/ 2017-09-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-63-5930540/ 2023-04-12T06:18:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newszydus-pharm-aid-enter-into-deal-for-varicella-vaccine-technology-in-russia-5929528/ 2017-09-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscook-group-signs-agreement-to-sell-cook-pharmica-to-catalent-for-950m-5929790/ 2017-09-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnew-study-suggests-jet-lag-drug-benefits-patients-undergoing-chemotherapy-5930008/ 2017-09-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuremining-fungi-a-fountain-of-new-medicines-5919883/ 2017-11-28T16:50:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsimmunocore-receives-funding-to-develop-immtav-and-immtab-therapeutics-for-infectious-diseases-5927937/ 2018-11-19T14:54:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnus-study-shows-artemisinin-ala-co-treatment-can-combat-cancer-cells-5928640/ 2017-09-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsteva-pharmaceutical-to-sell-assets-in-global-womens-health-business-for-138bn-5928713/ 2017-09-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentnovel-hyperkalemia-agents-race-toward-the-european-ckd-market-5929470/ 2017-09-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsaspen-enter-into-agreement-to-exercise-remaining-rights-for-astrazenecas-anaesthetic-therapies-5926963/ 2017-09-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-approval-for-mvasi-to-treat-five-types-of-cancer-5927061/ 2017-09-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-innoviva-receive-positive-opinion-from-chmp-for-trelegy-ellipta-to-treat-copd-5927589/ 2021-11-22T07:19:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentesmo-2017-an-uncertain-future-for-mercks-keytruda-5927099/ 2022-02-08T13:16:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-sepsis-and-septic-shock-treatment-to-be-a-59bn-market-by-2026-5921758/ 2017-09-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-pivot-pharmaceuticals-innovation-pharmaceuticals-portola-pharmaceuticals-5925363/ 2017-09-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-silver-falcon-plc-adcock-ingram-holdings-boya-bio-pharmaceutical-group-5925367/ 2021-12-01T13:13:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbristol-myers-squibb-to-use-halozymes-technology-to-develop-immuno-oncology-drugs-5926083/ 2021-11-22T06:48:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsevotec-and-mars-innovation-launch-new-drug-discovery-partnership-5926127/ 2017-09-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportemerging-rivals-in-car-t-cell-therapies-5925856/ 2017-09-14T05:02:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureosteoporosis-breakthrough-positive-news-in-a-field-plagued-by-bad-press-5921473/ 2023-01-04T11:11:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfujifilm-opens-new-cell-culture-process-development-laboratories-in-uk-5925171/ 2017-09-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmonopar-gets-licence-to-develop-onxeos-validive-oral-mucositis-treatment-5925184/ 2017-09-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-advisory-committee-votes-for-gsks-shingrix-to-prevent-shingles-in-adults-5925475/ 2017-09-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjanssen-to-stop-further-development-of-jnj-4178-hepatitis-c-treatment-5923752/ 2017-09-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspascal-biosciences-acquires-stc-technology-for-b-cell-precursor-all-treatment-5923922/ 2017-09-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsharbour-biomed-to-develop-and-commercialise-hanalls-biologic-therapies-in-greater-china-5924399/ 2021-11-22T06:37:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/lithuanias-drug-cost-containment-initiatives-getting-tough-on-off-patent-pricing-html/ 2021-11-02T03:30:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureone-in-five-why-the-uk-pharma-industry-is-going-to-court-over-spending-caps-5921092/ 2017-10-24T15:18:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsintegra-to-sell-neurosurgery-assets-to-natus-medical-5923313/ 2017-09-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssummit-therapeutics-gets-62m-contract-to-develop-ridinilazole-for-cdi-treatment-5923743/ 2017-09-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-exercises-global-licence-option-for-adaptimmunes-ny-eso-1-t-cell-therapy-5921025/ 2017-09-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsregeneron-and-sanofi-get-fdas-breakthrough-therapy-status-for-cscc-treatment-cemiplimab-5921365/ 2017-09-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmerck-and-project-data-sphere-to-join-forces-to-lead-big-data-alliance-5922568/ 2017-09-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-jhl-biotech-bio-techne-metabolon-5919976/ 2021-12-06T09:48:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-mundipharma-medical-company-cooper-pharmal-sarl-merck-kgaa-5920094/ 2021-11-22T12:39:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbioverativ-bicycle-therapeutics-to-develop-new-haemophilia-and-sickle-cell-disease-treatments-5920183/ 2017-09-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsboehringer-and-gubra-collaborate-to-discover-peptide-compounds-for-obesity-treatment-5920319/ 2017-09-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnih-awards-100m-in-funding-for-research-projects-on-autism-5920801/ 2023-05-31T05:07:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentan-update-on-parp-inhibitors-ovarian-cancer-and-beyond-5920314/ 2017-09-07T07:47:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssanofi-axxam-to-develop-lead-series-of-small-molecules-to-treat-cns-disorders-5918790/ 2017-09-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmerck-to-buy-german-company-rigontec-for-115m-5918979/ 2017-09-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsactelion-gets-fda-approval-for-32mg-tracleer-to-treat-paediatric-pah-patients-5919551/ 2017-09-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-rare-paediatric-disease-designation-for-novimmunes-hlh-treatment-emapalumab-5917768/ 2017-09-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstigenix-obtains-production-licence-for-expanded-adipose-derived-stem-cells-in-spain-5917881/ 2022-07-21T10:37:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnice-issues-second-draft-no-on-ninlaro-to-treat-myeloma-patients-on-nhs-5918345/ 2022-07-11T08:56:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureaugust-2017-top-news-stories-pharmaceutical-5910543/ 2017-09-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstherapure-biopharma-to-divest-its-cdmo-business-for-290m-5916462/ 2017-09-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstakeda-noile-immune-to-jointly-develop-new-car-t-immunotherapies-for-cancer-5916548/ 2017-09-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjanssen-mundipharma-sign-exclusive-distribution-deal-for-type-2-diabetes-treatments-in-eea-5917310/ 2017-09-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureis-amazon-gearing-up-to-take-on-the-us-pharmacy-market-5915816/ 2017-09-04T01:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssunovion-submits-nda-to-fda-for-dasotraline-to-treat-adhd-patients-5915779/ 2017-09-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newslabcorp-completes-acquisition-of-chiltern-for-12bn-5915783/ 2017-09-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizers-mylotarg-receives-fda-approval-for-acute-myeloid-leukaemia-treatment-5916368/ 2017-09-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentarray-biopharmas-brafmek-combination-set-for-approval-review-in-europe-5916621/ 2017-09-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/comment10-year-old-nice-restrictions-on-velcade-limit-patient-access-to-next-gen-therapies-5916648/ 2017-09-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-merck-kgaa-genius-lead-sanofi-5913408/ 2017-08-31T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-kymriah-gets-fda-approval-for-b-cell-precursor-all-treatment-5914378/ 2017-08-31T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-shenzhen-neptunus-bioengineering-denis-chem-lab-humanwell-healthcare-5914891/ 2017-08-31T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsamgens-mimpara-for-secondary-hpt-children-with-esrd-gets-marketing-approval-in-eu-5915123/ 2017-08-31T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentfda-rejection-of-acordas-inbrija-is-another-challenge-after-ampyra-patent-setback-5915282/ 2017-08-31T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentwhy-has-the-industry-seen-higher-numbers-of-drug-designations-than-ever-before-5915288/ 2017-08-31T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdaiichi-sankyo-to-end-agreement-with-charleston-laboratories-for-hydrocodone-products-5915392/ 2017-08-31T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseuropean-commission-licenses-eusas-advanced-rcc-treatment-fotivda-5913136/ 2017-08-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsema-accepts-pfizers-regulatory-applications-for-bosulif-to-treat-ph-cml-patients-5913586/ 2022-07-11T08:56:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-study-reveals-role-of-proteins-in-treating-colorectal-cancer-5913768/ 2017-08-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentesc-congress-barcelona-2017-highlights-what-is-the-role-of-monotherapies-in-the-treatment-of-pah-patients-5914552/ 2022-07-11T08:56:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commenthigh-multiple-sclerosis-costs-are-attracting-attention-from-us-lawmakers-5912846/ 2017-08-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-astrazenecas-faslodex-for-expanded-use-in-breast-cancer-5911706/ 2017-08-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgenmab-seattle-genetics-to-co-develop-tisotumab-vedotin-for-solid-tumours-5911871/ 2017-08-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsimmunogen-jazz-collaborate-to-develop-and-market-adc-products-5912539/ 2017-08-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentdespite-humira-patent-expiry-abbvie-is-poised-to-remain-a-market-leader-in-crohns-disease-5912840/ 2017-08-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportjapan-leads-in-preventing-cdi-recurrences-5911245/ 2017-08-29T04:11:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/spain-bets-on-barcelona-to-get-the-ema-as-the-independence-movement-in-catalonia-reaches-climax-html/ 2021-11-02T03:25:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-accepts-genentechs-sbla-for-gazyva-to-treat-untreated-follicular-lymphoma-5909924/ 2017-08-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssanofi-completes-acquisition-of-protein-sciences-for-750m-5910136/ 2017-08-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgilead-sciences-to-buy-kite-pharma-for-119bn-5911030/ 2017-08-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentthe-future-of-vaccines-could-they-really-grow-on-trees-5911231/ 2017-08-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportthe-quest-for-efficient-and-cost-effective-rd-remains-a-challenge-5911798/ 2017-08-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentparp-inhibitors-are-set-to-become-the-new-standard-of-care-in-brca12-mutated-pancreatic-adenocarcinoma-5911836/ 2017-08-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-jazz-pharmaceuticals-kangmei-pharmaceutical-5907434/ 2017-08-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-clinigen-group-mekong-capital-5907441/ 2017-08-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-accepts-roches-bla-for-emicizumab-to-treat-haemophilia-a-5908930/ 2017-08-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsec-approves-novartis-kisqali-for-advanced-breast-cancer-treatment-in-women-5908977/ 2017-08-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscrispr-massachusetts-general-hospital-collaborate-to-develop-t-cell-therapies-5907842/ 2017-08-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsicr-researchers-discover-use-of-existing-drug-in-treating-oesophageal-cancer-5907896/ 2017-08-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsumi3-gives-exclusive-licence-for-sentragor-to-arriani-pharmaceuticals-5908476/ 2017-08-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentcould-the-first-new-sickle-cell-drug-in-20-years-provide-hope-for-sufferers-5909117/ 2023-09-12T04:05:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentnovartis-launches-first-smartphone-based-study-in-ms-5909118/ 2017-08-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentanti-nerve-growth-factor-antibodies-expected-to-drive-osteoarthritis-market-growth-5909129/ 2017-08-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-62-5907980/ 2023-04-12T06:18:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsorchards-otl-101-receives-promising-medicine-designation-for-ada-scid-in-uk-5906569/ 2017-08-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsac-immune-finds-new-antibodies-targeting-neurodegenerative-diseases-5906582/ 2017-08-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstopas-and-eli-lilly-sign-deal-to-focus-on-immune-tolerance-5907031/ 2017-08-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportaeds-targeting-rare-epilepsy-syndromes-set-to-shoot-to-top-of-the-market-5908092/ 2017-08-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmimedx-to-divest-stability-biologics-business-to-focus-on-biopharma-5905091/ 2017-08-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssandozs-erelzi-available-for-multiple-inflammatory-disease-treatment-in-canada-5905309/ 2017-08-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstakeda-submits-nda-for-moderate-to-severe-uc-treatment-in-japan-5905797/ 2017-08-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizers-besponsa-gets-fda-approval-for-treatment-of-b-cell-precursor-all-5904109/ 2017-08-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newschampions-oncology-to-collaborate-with-alcmi-to-develop-new-cohort-of-pdx-models-5904663/ 2017-08-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-ethris-to-develop-new-mrna-treatments-for-respiratory-diseases-5904876/ 2018-11-19T14:52:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurezika-virus-an-unlikely-new-anti-cancer-candidate-5905375/ 2017-08-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-kadmon-holdings-antares-pharma-vicarius-pharma-5902210/ 2017-08-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-guanhao-biotech-cancer-genetics-alvogen-5902242/ 2017-08-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscancer-research-uk-newcastle-university-extend-drug-discovery-partnership-with-astex-5902786/ 2017-08-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssillajen-nci-partner-to-develop-new-colorectal-cancer-treatment-5903682/ 2017-08-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newshikma-takeda-collaborate-to-expand-product-portfolio-in-mena-5903696/ 2017-08-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/irp-rumblings-an-eclipse-of-traditional-market-access-strategy-html/ 2021-11-02T03:25:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsshire-submits-marketing-application-for-lifitegrast-to-treat-dry-eye-disease-in-europe-5901556/ 2017-08-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsevotec-buys-aptuit-for-nearly-300m-5902264/ 2017-08-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjohnson-johnson-and-csir-imtech-partner-to-discover-new-tuberculosis-treatments-5902287/ 2017-08-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-orphan-drug-status-to-h3-biomedicines-cancer-treatment-h3b-8800-5900828/ 2017-08-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsaradigm-gets-sbir-grant-to-investigate-use-of-linhaliq-and-lipoquin-for-pntm-treatment-5901330/ 2017-08-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsamicus-galafold-gets-tga-approval-for-fabry-disease-treatment-in-australia-5901391/ 2023-07-31T07:08:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsthree-quarters-of-cdf-drugs-approved-for-cancer-patients-on-nhs-says-report-5899675/ 2017-08-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmundipharma-acquires-global-rights-for-cellacts-biliary-tract-cancer-treatment-cap71-5900166/ 2017-08-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmylan-launches-three-generic-antiretroviral-treatments-for-hiv-patients-in-canada-5898586/ 2022-07-11T08:56:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstakeda-and-shattuck-labs-partner-to-develop-immunotherapies-for-cancer-treatments-5898672/ 2017-08-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssk-capital-to-buy-api-business-from-perrigo-company-5899668/ 2017-08-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-biomarin-pharmaceutical-spectrum-pharmaceuticals-orient-pharma-5896897/ 2017-08-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-sun-pharmaceutical-industries-northeast-pharmaceutical-group-mallinckrodt-5896908/ 2017-08-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newswuxi-apptec-report-shows-prospects-of-immunotherapy-treatments-for-cancer-5897689/ 2017-08-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-orphan-drug-designation-to-ocugens-ocu300-for-ogvhd-treatment-5897841/ 2017-08-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjuniper-pharma-and-crystecpharma-to-create-new-drug-development-platform-5898357/ 2017-08-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-recommends-mercks-erbitux-for-treatment-of-rm-scchn-in-oral-cavity-5896504/ 2017-08-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgalena-biopharma-merges-sellas-to-form-a-new-combined-company-5896508/ 2017-08-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnumerate-gets-nih-funding-to-discover-new-antiarrhythmic-treatments-5897048/ 2017-08-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentwith-melinta-merger-cempra-lands-on-its-feet-despite-regulatory-struggles-5897615/ 2017-08-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssmc-approves-amgens-carfilzomib-for-multiple-myeloma-treatment-in-nhs-5894833/ 2017-08-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsstudy-reveals-antiulcer-treatment-do-not-enhance-risk-of-alzheimers-disease-5894951/ 2017-08-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-to-host-first-cannatech-summit-in-october-this-year-5895105/ 2017-08-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportnovartis-leads-japanese-clinical-trials-5894652/ 2017-10-26T11:40:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurenew-library-building-the-linc-between-pharmaceutical-industry-and-academia-5885401/ 2017-11-21T18:05:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-recommends-nhs-use-of-celgenes-pancreatic-cancer-treatment-abraxane-5893483/ 2017-08-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newstokyo-tech-to-research-on-computational-drug-discovery-of-middle-molecules-in-kawasaki-japan-5893593/ 2017-08-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbayers-stivarga-receives-eu-marketing-approval-for-hcc-treatment-5894367/ 2017-08-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureaugusts-top-stories-5889730/ 2021-10-27T12:53:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-research-shows-common-drug-methotrexate-can-treat-polycythemia-vera-5892594/ 2017-08-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmallinckrodt-to-buy-infacare-and-its-paediatric-jaundice-treatment-stannsoporfin-5892894/ 2017-08-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbristol-myers-squibb-to-buy-ifm-therapeutics-for-300m-5892988/ 2017-08-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/in-china-drugmakers-walk-increasingly-fine-line-between-lower-prices-and-making-a-buck-html/ 2021-11-02T03:25:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-innoviva-seattle-genetics-plasmagen-biosciences-5890162/ 2021-11-22T07:19:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-eurofins-scientific-baxter-international-5890173/ 2017-08-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-global-her2-positive-breast-cancer-market-set-to-reach-989bn-by-2025-5890515/ 2017-08-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstakeda-cardurion-collaborate-to-develop-new-heart-disease-treatments-5890757/ 2017-08-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-imbruvica-for-treatment-of-cgvhd-5890896/ 2017-08-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentbms-shifts-towards-precision-medicine-5891350/ 2017-08-03T08:26:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-grants-breakthrough-therapy-designation-for-astrazenecas-mcl-treatment-5888965/ 2017-08-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscollidion-to-buy-80-stake-in-plex-pharmaceuticals-5889596/ 2017-08-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-invites-roche-to-submit-cdf-proposal-for-urothelial-cancer-treatment-atezolizumab-5890484/ 2017-08-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newskite-pharma-submits-maa-for-axicabtagene-ciloleucel-in-europe-5888166/ 2017-08-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssta-pharmaceutical-merges-with-wuxis-pharmaceutical-development-division-5888223/ 2022-07-11T09:04:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsindian-government-cancels-fosuns-13bn-proposal-to-buy-gland-pharma-5888924/ 2017-08-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreporttop-sponsors-for-2007-2016-stem-cell-therapy-clinical-trials-5887802/ 2017-10-26T11:43:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportnanobodies-leading-the-way-for-biotech-rd-deal-5887698/ 2017-08-01T03:58:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentpsivida-and-alimera-enter-new-phase-of-collaboration-on-the-longest-acting-ocular-steroid-implant-5887699/ 2023-02-27T05:52:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentamgen-and-array-biopharma-partnership-creating-waves-in-autoimmune-disorder-market-5887687/ 2017-08-01T03:48:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentdynavaxs-heplisav-b-passes-key-regulatory-hurdle-with-fda-advisory-committee-endorsement-5887684/ 2017-08-01T03:47:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsabbvie-receives-ec-grant-to-market-hcv-treatment-maviret-5886479/ 2017-07-31T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsokayama-university-researchers-identify-clodronate-for-chronic-pain-treatment-5886615/ 2017-07-31T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newslabcorp-to-buy-chiltern-for-about-12bn-5887478/ 2017-07-31T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentthe-role-of-the-media-in-determining-health-views-5886889/ 2017-07-31T09:37:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentfighting-obesity-past-and-future-treatments-5886876/ 2017-07-31T08:57:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commenteli-lilly-makes-strategic-decision-5886827/ 2017-07-31T07:59:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbavarian-nordic-and-janssen-collaborate-to-develop-vaccines-against-hiv-1-and-hepatitis-b-5884820/ 2017-07-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbaxter-completes-acquisition-of-claris-injectables-for-nearly-625m-5884839/ 2017-07-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureclosing-the-us-pharmaceutical-industrys-growing-skills-gap-5885395/ 2017-11-21T18:07:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmerck-and-astrazeneca-to-develop-and-market-lynparza-for-multiple-cancer-treatments-5885875/ 2017-07-30T17:30:00+00:00 daily 1.0 https://www.pharmaceutical-technology.com/comment/commenta-blueprint-to-immunotherapy-combinations-5885408/ 2017-07-28T10:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentq2-results-of-gileads-hcv-portfolio-could-spell-future-success-for-abbvie-5885404/ 2017-07-28T09:46:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/what-next-for-us-healthcare-reform-as-senate-fails-to-pass-aca-repeal-bill-html/ 2021-11-02T03:26:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-fidson-healthcare-sarepta-therapeutics-north-china-pharmaceutical-5883403/ 2017-07-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-clostridium-difficile-infections-market-to-reach-17bn-by-2026-5883581/ 2017-07-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazenecas-faslodex-receives-eu-approval-for-advanced-breast-cancer-treatment-5883683/ 2017-07-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseisai-seeks-marketing-authorisation-for-lenvatinib-from-ema-5884508/ 2017-07-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentwhich-niche-disease-could-be-set-to-see-a-treatment-breakthrough-and-multi-billion-dollar-revenues-5885388/ 2022-12-02T12:11:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commenta-vaccine-for-lyme-disease-second-time-lucky-5885389/ 2017-07-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commenttensions-rise-as-uk-pharma-industry-takes-government-to-court-5885397/ 2017-07-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsviiv-reaches-another-milestone-in-the-development-of-a-long-acting-hiv-regimen-5884700/ 2017-07-27T09:50:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentstrong-safety-and-efficacy-data-position-aerie-pharmaceuticals-to-submit-glaucoma-nda-for-roclatan-5884572/ 2023-04-14T06:20:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-study-discovers-faulty-genes-underlying-brain-tumours-5882983/ 2023-03-10T06:03:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssandoz-to-improve-treatment-access-to-children-with-cancer-in-four-developing-nations-5883115/ 2017-07-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-fast-track-designation-for-ablynxs-caplacizumab-to-treat-attp-5883181/ 2017-07-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentnice-too-nice-for-too-long-5884606/ 2017-07-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentsamsungs-move-towards-pharmaceuticals-is-paying-off-5884684/ 2017-07-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentwill-lampalizumab-finally-provide-a-treatment-for-muscular-degeneration-5882794/ 2021-12-01T12:34:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurephrma-resetting-the-conversation-5880995/ 2021-04-14T15:06:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssta-pharmaceutical-signs-deal-with-tesaro-for-zejula-5881345/ 2017-07-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-files-supplementary-nda-for-asthma-treatment-arnuity-ellipta-5881393/ 2017-07-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsantabio-to-develop-pseudomonas-infections-treatment-in-cystic-fibrosis-5882155/ 2017-07-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportearly-detection-of-invasive-breast-cancer-substandard-in-urban-china-5881712/ 2017-07-25T09:42:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportanti-diabetic-treatments-with-non-glycemic-benefits-driver-of-growth-5880862/ 2017-07-25T04:03:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseli-lilly-and-nektar-partner-to-develop-new-immunological-therapy-nktr-358-5880521/ 2017-07-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmitsubishi-tanabe-pharma-to-buy-neuroderm-for-11bn-5880613/ 2017-07-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjanssen-gets-ema-committee-recommendation-to-market-symtuza-for-hiv-5881107/ 2017-07-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentgilead-looks-to-maintain-dominance-in-hiv-with-its-novel-str-5881716/ 2017-07-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuredo-healthcare-cuts-risk-creating-a-desert-for-innovation-in-the-uk-5864811/ 2022-04-15T15:48:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-approves-new-tolerable-drug-carflizomib-for-multiple-myeloma-patients-on-nhs-5877024/ 2017-07-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsrecipharm-and-lidds-sets-up-prostate-cancer-drug-development-facility-in-sweden-5878160/ 2017-07-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsemas-chmp-recommends-merck-and-pfizers-cancer-drug-avelumab-for-approval-5879925/ 2023-02-03T08:53:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-hugel-guangdong-zhongsheng-pharmaceutical-valeant-pharmaceuticals-international-5876058/ 2021-12-01T13:08:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-northeast-pharmaceutical-group-principia-sgr-commelina-limited-5876066/ 2017-07-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-canadian-pharmaceuticals-market-to-witness-a-nominal-cagr-of-2-up-to-2021-5877054/ 2017-07-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsablynx-and-sanofi-collaborate-for-nanobody-based-inflammatory-disease-treatments-5877483/ 2017-07-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-recommends-tevas-cinqaero-to-treat-severe-eosinophilic-asthma-5877549/ 2017-07-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportus-faces-high-growing-burden-of-cdi-5878578/ 2017-07-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurebetting-big-on-gamma-delta-t-cells-5864573/ 2017-07-20T03:57:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgileads-vosevi-receives-fda-approval-for-re-treatment-of-chronic-hcv-5875727/ 2017-07-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newselsalys-biotech-and-dkfz-collaborate-to-develop-elb021-in-b-cell-leukaemia-5876108/ 2017-07-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-to-invest-additional-140m-at-uk-manufacturing-sites-5876366/ 2017-07-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentarena-pharmaceuticals-positive-topline-phase-ii-results-for-ralinepag-pose-threat-for-jjs-uptravi-5876555/ 2017-07-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportdespite-challenges-pain-related-indications-are-most-frequently-researched-clinical-trials-5876721/ 2017-10-26T11:40:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-61-5875781/ 2023-04-21T09:48:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsvaleant-to-sell-obagi-medical-products-business-for-190m-5873865/ 2017-07-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsresearch-team-discovers-epithelial-cells-in-eyes-can-prevent-spread-of-ebola-5873975/ 2017-07-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurecystic-fibrosis-searching-for-a-breakthrough-5874315/ 2017-07-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstakeda-and-prana-to-study-neurodegeneration-treatment-for-parkinsons-disease-5875087/ 2017-07-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentthe-nhs-hopes-that-data-and-the-model-hospital-will-save-it-money-5873709/ 2017-07-18T04:25:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreporthealthcare-related-cdis-rivaled-by-community-cases-5873692/ 2017-07-18T04:16:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/irp-is-dead-long-live-irp-html-2/ 2021-11-02T03:26:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-asks-for-additional-data-to-approve-evenity-in-us-5873651/ 2017-07-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsudg-healthcare-to-acquire-cambridge-biomarketing-for-up-to-35m-5873670/ 2017-07-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsroches-ocrevus-receives-tga-approval-for-rms-and-ppms-treatment-in-australia-5873690/ 2017-07-17T17:30:00+00:00 daily 0.2